The metabolism of testosterone in vitro by normal benign hyperplastic and carcinomatous prostatic tissues has been compared. 5α-Dihydrotestosterone was the predominant metabolite followed by 3α- and 3β-androstanediol. No difference in the pattern of metabolism, either quantitatively or qualitatively, was found in normal, benign hyperplastic and welldifferentiated carcinomatous prostatic tissue. In poorly differentiated carcinomatous tissue there was less formation of all 5α-reduced metabolites. Treatment of patients with carcinomata with diethylstilboestrol resulted in greatly decreased activity of prostatic 5α-reductase with a considerable proportional increase in 17β-dehydrogenase activity. The addition of oestradiol-17β or stilboestrol in vitro also inhibited the formation of 5αdihydrotestosterone and androstanediols by all types of prostatic tissue, but only when high concentrations of oestrogen were used and there was no increase in 17β-dehydrogenase under these conditions. In contrast, progesterone was a much more effective inhibitor of 5α-reductase in vitro than was oestrogen.
Journal of Endocrinology is committed to supporting researchers in demonstrating the impact of their articles published in the journal.
The two types of article metrics we measure are (i) more traditional full-text views and pdf downloads, and (ii) Altmetric data, which shows the wider impact of articles in a range of non-traditional sources, such as social media.
More information is on the Reasons to publish page.
| Sept 2018 onwards | Past Year | Past 30 Days | |
|---|---|---|---|
| Full Text Views | 1 | 1 | 0 |
| PDF Downloads | 3 | 1 | 0 |
Online ISSN: 1479-6805
Print ISSN: 0022-0795
Strengthening biomedical communities
to advance science and health
CONTACT US
Bioscientifica Ltd | Starling House | 1600 Bristol Parkway North | Bristol BS34 8YU | UK
Bioscientifica Ltd | Registered in England no 3190519
